CM
Castleark Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-110,880
| Closed | -$4.02M | – | 310 |
|
|
2023
Q1 | $4.02M | Buy |
110,880
+52,440
| +90% | +$1.9M | 0.2% | 118 |
|
|
2022
Q4 | $2.08M | Buy |
58,440
+1,050
| +2% | +$37.5K | 0.11% | 162 |
|
|
2022
Q3 | $1.94M | Sell |
57,390
-14,600
| -20% | -$494K | 0.11% | 152 |
|
|
2022
Q2 | $2.08M | Buy |
71,990
+30,010
| +71% | +$868K | 0.11% | 154 |
|
|
2022
Q1 | $1.36M | Buy |
+41,980
| New | +$1.36M | 0.06% | 203 |
|
|
2019
Q1 | – | Sell |
-4,280
| Closed | -$142K | – | 403 |
|
|
2018
Q4 | $142K | Hold |
4,280
| – | – | 0.01% | 345 |
|
|
2018
Q3 | $215K | Sell |
4,280
-297,565
| -99% | -$14.9M | 0.01% | 349 |
|
|
2018
Q2 | $18.1M | Buy |
+301,845
| New | +$18.1M | 0.56% | 44 |
|
|
2017
Q4 | – | Sell |
-316,940
| Closed | -$12.7M | – | 440 |
|
|
2017
Q3 | $12.7M | Buy |
316,940
+93,590
| +42% | +$3.74M | 0.4% | 81 |
|
|
2017
Q2 | $9.63M | Sell |
223,350
-57,741
| -21% | -$2.49M | 0.31% | 106 |
|
|
2017
Q1 | $8.8M | Sell |
281,091
-49,450
| -15% | -$1.55M | 0.28% | 117 |
|
|
2016
Q4 | $8.35M | Sell |
330,541
-27,835
| -8% | -$703K | 0.27% | 130 |
|
|
2016
Q3 | $8.86M | Sell |
358,376
-85,785
| -19% | -$2.12M | 0.27% | 117 |
|
|
2016
Q2 | $9.05M | Buy |
444,161
+218,399
| +97% | +$4.45M | 0.29% | 97 |
|
|
2016
Q1 | $3.44M | Sell |
225,762
-33,510
| -13% | -$511K | 0.11% | 209 |
|
|
2015
Q4 | $3.49M | Sell |
259,272
-115,115
| -31% | -$1.55M | 0.1% | 214 |
|
|
2015
Q3 | $5.25M | Sell |
374,387
-66,138
| -15% | -$928K | 0.17% | 153 |
|
|
2015
Q2 | $7.48M | Buy |
+440,525
| New | +$7.48M | 0.2% | 139 |
|